Page last updated: 2024-10-21

acebutolol and Laryngeal Neoplasms

acebutolol has been researched along with Laryngeal Neoplasms in 2 studies

Acebutolol: A cardioselective beta-1 adrenergic antagonist with little effect on the bronchial receptors. The drug has stabilizing and quinidine-like effects on cardiac rhythm, as well as weak inherent sympathomimetic action.
acebutolol : An ether that is the 2-acetyl-4-(butanoylamino)phenyl ether of the primary hydroxy group of 3-(propan-2-ylamino)propane-1,2-diol.

Laryngeal Neoplasms: Cancers or tumors of the LARYNX or any of its parts: the GLOTTIS; EPIGLOTTIS; LARYNGEAL CARTILAGES; LARYNGEAL MUSCLES; and VOCAL CORDS.

Research Excerpts

ExcerptRelevanceReference
"The successful management of subglottic hemangioma with propranolol has been reported."7.76Management of infantile subglottic hemangioma: acebutolol or propranolol? ( Amedro, P; Bigorre, M; Blanchet, C; Mondain, M; Nicollas, R, 2010)
"The successful management of subglottic hemangioma with propranolol has been reported."3.76Management of infantile subglottic hemangioma: acebutolol or propranolol? ( Amedro, P; Bigorre, M; Blanchet, C; Mondain, M; Nicollas, R, 2010)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Blanchet, C1
Nicollas, R1
Bigorre, M1
Amedro, P1
Mondain, M1
Leboulanger, N1
Cox, A1
Garabedian, EN1
Denoyelle, F1

Reviews

1 review available for acebutolol and Laryngeal Neoplasms

ArticleYear
Infantile haemangioma and β-blockers in otolaryngology.
    European annals of otorhinolaryngology, head and neck diseases, 2011, Volume: 128, Issue:5

    Topics: Acebutolol; Adrenergic beta-Antagonists; Dose-Response Relationship, Drug; Hemangioma; Humans; Infan

2011

Other Studies

1 other study available for acebutolol and Laryngeal Neoplasms

ArticleYear
Management of infantile subglottic hemangioma: acebutolol or propranolol?
    International journal of pediatric otorhinolaryngology, 2010, Volume: 74, Issue:8

    Topics: Acebutolol; Adrenergic beta-Antagonists; Dose-Response Relationship, Drug; Drug Administration Sched

2010